Pernix Announces Pricing of $28M Offering of Common Stock at $7.00 per Share

Pernix Therapeutics Holdings, Inc.

today announced the pricing of an underwritten registered direct offering of 4,000,000 shares of common stock at a price of $7.00 per share. The offering, led by Aisling Capital and OrbiMed Advisors LLC, consists of 3,000,000 shares of primary stock and 1,000,000 shares of secondary stock.